Valuation: BOIRON

Market Cap 345M 388M 322M 293M 553M 37.29B 558M 3.89B 1.51B 19.06B 1.46B 1.42B 61.18B P/E 2024
41x
P/E 2025 16.1x
Enterprise Value 297M 334M 277M 252M 476M 32.11B 481M 3.35B 1.3B 16.42B 1.25B 1.23B 52.68B EV / Sales 2024
0.85x
EV / Sales 2025 0.95x
Free-Float
19.96%
Yield 2024
4.48%
Yield 2025 4.46%
1 day-0.25%
1 week+1.02%
Current month-1.00%
1 month-24.43%
3 months-28.26%
6 months-29.29%
Current year-34.65%
1 week 19.3
Extreme 19.3
20.9
1 month 19.3
Extreme 19.3
26.7
Current year 19.3
Extreme 19.3
30.95
1 year 19.3
Extreme 19.3
32.25
3 years 19.3
Extreme 19.3
56.5
5 years 19.3
Extreme 19.3
56.5
10 years 19.3
Extreme 19.3
92.91
Manager TitleAgeSince
Chief Executive Officer 57 01/01/2025
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 01/01/2022
Director TitleAgeSince
Chairman 65 01/07/2011
Director/Board Member 54 10/03/2010
Director/Board Member 51 23/05/2013
Date Insider Type Main position Quantity % Market Cap. Importance
10/29/23 A Sell

Director

198,664 1.1323%
10/29/23 A Sell

Director

462,964 2.6387%
10/29/23 A Sell

Director

4,748 0.0271%
Change 5-day change 1-year change 3-year change Capi.($)
-0.25%+1.02%-26.39%-63.33% 388M
-0.31%-3.28%+39.62%+112.65% 1,025B
-1.23%-5.87%+37.27%+64.55% 623B
+1.42%-0.44%+11.25%+77.52% 459B
+0.23%-3.22%+60.86%+40.41% 355B
-0.95%-4.05%+21.60%+39.37% 336B
-1.46%-2.89%+11.84%+24.60% 270B
-1.35%-5.43%-4.69%+8.40% 247B
-0.95%-2.75%+35.57%+51.40% 220B
-2.08%-4.18%+30.81%+95.17% 183B
Average -0.72%-2.20%+21.78%+45.07% 371.86B
Weighted average by Cap. -0.56%-2.42%+30.49%+68.92%

Financials

2024 2025
Net sales 488M 549M 455M 415M 782M 52.75B 790M 5.51B 2.13B 26.97B 2.06B 2.02B 86.55B 501M 564M 468M 426M 804M 54.22B 811M 5.66B 2.19B 27.72B 2.12B 2.07B 88.95B
Net income 11.34M 12.76M 10.58M 9.64M 18.19M 1.23B 18.36M 128M 49.62M 627M 47.9M 46.86M 2.01B 32.64M 36.74M 30.47M 27.77M 52.37M 3.53B 52.86M 369M 143M 1.81B 138M 135M 5.79B
Net Debt -49.74M -55.98M -46.42M -42.31M -79.8M -5.38B -80.54M -562M -218M -2.75B -210M -206M -8.83B -47.86M -53.86M -44.66M -40.71M -76.78M -5.18B -77.49M -541M -209M -2.65B -202M -198M -8.49B
Logo BOIRON
Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both urban and hospital settings. All actions aim to contribute to major public health issues. Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin. There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties). BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries. Net sales are distributed geographically as follows: France (43.5%), Europe (24%), North America (27.5%) and other (5%).
Employees
2,623
Date Price Change Volume
02/10/26 €19.80 -0.25% 5,364
01/10/26 €19.85 -0.75% 5,359
30/09/26 €20.00 0.00% 2,870
29/09/26 €20.00 +0.25% 2,684
28/09/26 €19.95 +1.79% 1,957

Annual profits - Rate of surprise